Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Debernardo · SciRah

Researcher profile · Semantic Scholar

R. Debernardo

Share profile

R. Debernardo — researcher profile on SciRah

h-index: 25
Works: 157
Citations: 2,638

Most-cited papers

IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection.
Souheil-Antoine Younes, M. Freeman, Joseph C. Mudd, C. Shive +19 more
2016Journal of Clinical Investigation105 citations Open access
Semantic Scholar
Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival?
A. Fader, J. Bergstrom, A. Jernigan, E. Tanner +14 more
2016Gynecologic Oncology96 citations
Semantic Scholar
CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors
C. Saygin, Andrew C Wiechert, V. Rao, R. Alluri +20 more
2017bioRxiv91 citations Open access
Semantic Scholar
Impact of antibiotic treatment during platinum chemotherapy on survival and recurrence in women with advanced epithelial ovarian cancer.
L. Chambers, M. Kuznicki, M. Yao, A. Chichura +6 more
2020Gynecologic Oncology37 citations
Semantic Scholar
A guide to establishing a hyperthermic intraperitoneal chemotherapy program in gynecologic oncology.
L. Chambers, A. Costales, K. Crean-Tate, M. Kuznicki +7 more
2020Gynecologic Oncology31 citations
Semantic Scholar
Modified frailty index predicts postoperative complications in women with gynecologic cancer undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
L. Chambers, Julia Chalif, M. Yao, A. Chichura +9 more
2021Gynecologic Oncology30 citations
Semantic Scholar
Case study: patient-derived clear cell adenocarcinoma xenograft model longitudinally predicts treatment response
R. Vargas, P. Gopal, Gwendolyn B. Kuzmishin, R. Debernardo +7 more
2018npj Precision Oncology25 citations Open access
Semantic Scholar
PARP inhibitors decrease response to subsequent platinum-based chemotherapy in patients with BRCA mutated ovarian cancer
P. Rose, M. Yao, L. Chambers, H. Mahdi +5 more
2021Anti-Cancer Drugs23 citations
Semantic Scholar
Assessing feasibility and perioperative outcomes with minimally invasive surgery compared with laparotomy for interval debulking surgery with hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian cancer
M. Morton, L. Chambers, A. Costales, A. Chichura +6 more
2020Gynecologic Oncology23 citations Open access
Semantic Scholar
Effects of the WRITE Symptoms Interventions on Symptoms and Quality of Life Among Patients With Recurrent Ovarian Cancers: An NRG Oncology/GOG Study (GOG-0259)
H. Donovan, S. Sereika, L. Wenzel, R. Edwards +14 more
2022Journal of Clinical Oncology21 citations Open access
Semantic Scholar
Mechanistic Insights on Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
Olivia G Huffman, D. Chau, Andreea I. Dinicu, R. Debernardo +1 more
2023Cancers19 citations Open access
Semantic Scholar
Use of Prophylactic Closed Incision Negative Pressure Therapy Is Associated with Reduced Surgical Site Infections in Gynecologic Oncology Patients Undergoing Laparotomy.
L. Chambers, M. Morton, Erika J. Lampert, M. Yao +3 more
2020American Journal of Obstetrics and Gynecology18 citations
Semantic Scholar
Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcoma
Jonathan T. Hunt, L. Chambers, M. Yao, A. Joehlin-Price +2 more
2021Gynecologic Oncology Reports17 citations Open access
Semantic Scholar
Patterns of recurrence in women with advanced and recurrent epithelial ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
L. Chambers, M. Yao, M. Morton, M. Gruner +6 more
2021Gynecologic Oncology16 citations
Semantic Scholar
Pretreatment with LCK inhibitors chemosensitizes cisplatin‐resistant endometrioid ovarian tumors
K. Crean-Tate, C. Braley, G. Dey, E. Esakov +10 more
2020bioRxiv14 citations Open access
Semantic Scholar
Long-term use of pegylated liposomal doxorubicin to a cumulative dose of 4600 mg/m2 in recurrent ovarian cancer.
A. Pendlebury, R. Debernardo, P. Rose
2017Anti-Cancer Drugs14 citations
Semantic Scholar
Alteration in PI3K/mTOR, MAPK pathways and Her2 expression/amplification is more frequent in uterine serous carcinoma than ovarian serous carcinoma
H. Mahdi, J. Xiu, S. Reddy, R. Debernardo
2015Journal of Surgical Oncology14 citations
Semantic Scholar
Physiologic tension of the abdominal wall
B. Miller, R. Ellis, R. Walsh, D. Joyce +9 more
2023Surgical Endoscopy12 citations
Semantic Scholar
Anastomotic leak following interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in women with advanced epithelial ovarian Cancer.
M. Gruner, L. Chambers, M. Yao, A. Chichura +6 more
2021Gynecologic Oncology12 citations
Semantic Scholar
Phase II Evaluation of Dalantercept in the Treatment of Persistent or Recurrent Epithelial Ovarian Cancer: an NRG Oncology/Gynecologic Oncology Group Study
R. Burger, W. Deng, V. Makker, Y. Collins +4 more
2018Gynecologic Oncology12 citations Open access
Semantic Scholar
Association of Clinical Trial Participation With Improved Overall Survival for Recurrent, Platinum-Resistant Ovarian Cancer
M. Morton, M. Yao, Julia Chalif, Erika J. Lampert +6 more
2023Obstetrics and Gynecology11 citations
Semantic Scholar
Impact of intra-operative factors upon peri-operative outcomes in women undergoing hyperthermic intraperitoneal chemotherapy for gynecologic cancer.
A. Chichura, L. Chambers, A. Costales, M. Yao +6 more
2021Gynecologic Oncology11 citations
Semantic Scholar
Incidence and prognostic significance of inguinal lymph node metastasis in women with newly diagnosed epithelial ovarian cancer.
Julia Chalif, M. Yao, M. Gruner, M. Kuznicki +5 more
2022Gynecologic Oncology9 citations
Semantic Scholar
Evaluation of non-completion of intraperitoneal chemotherapy in patients with advanced epithelial ovarian cancer
L. Chambers, J. Son, M. Radeva, R. Debernardo
2019Journal of Gynecologic Oncology9 citations Open access
Semantic Scholar
Safety and efficacy of topical artesunate for the treatment of vulvar intraepithelial neoplasia 2/3.
C. Michener, Stephanie Ricci, Mariam Alhilli, Lindsey Beffa +6 more
2023Gynecologic Oncology8 citations
Semantic Scholar
Assessment of travel distance for hyperthermic intraperitoneal chemotherapy in women with ovarian cancer
L. Chambers, M. Yao, M. Morton, M. Gruner +6 more
2022Gynecologic Oncology Reports7 citations Open access
Semantic Scholar
Perioperative outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in elderly women with epithelial ovarian cancer: analysis of a prospective registry
L. Chambers, M. Yao, M. Morton, A. Chichura +6 more
2021International Journal of Gynecological Cancer7 citations Open access
Semantic Scholar
Incidence of squamous cell carcinomas of the head and neck following prolonged pegylated liposomal doxorubicin
P. Rose, F. Fu, L. Chambers, L. Mei +3 more
2020Anti-Cancer Drugs7 citations
Semantic Scholar
Efficacy and toxicity of prolonged pegylated liposomal doxorubicin use in women with recurrent epithelial ovarian cancer.
L. Chambers, A. Pendlebury, P. Rose, M. Yao +1 more
2020Gynecologic Oncology7 citations
Semantic Scholar
Effect of platinum sensitivity on the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in recurrent epithelial ovarian cancer.
A. Costales, L. Chambers, A. Chichura, P. Rose +4 more
2020Journal of Gynecology Obstetrics and Human Reproduction6 citations
Semantic Scholar
The modified 5-factor frailty index predicts postoperative outcomes in patients with ovarian cancer undergoing hyperthermic intraperitoneal chemotherapy.
Johanna Kelley, Gabriella Smith, Meng Yao, L. Chambers +1 more
2024Surgical oncology5 citations
Semantic Scholar
A Phase 2 Study of Dasatinib in Recurrent Clear Cell Carcinoma of the Ovary, Fallopian Tube, Peritoneum or Endometrium: NRG Oncology/Gynecologic Oncology Group Study 0283
R. O'Cearbhaill, Austin Miller, R. Soslow, H. Lankes +11 more
2023Gynecologic Oncology5 citations Open access
Semantic Scholar
Stereotactic Body Radiotherapy for the Treatment of Oligometastatic Gynecological Malignancy in the Abdomen and Pelvis: A Single-Institution Experience
T. Smile, C. Reddy, G. Qiao-Guan, S. Amarnath +9 more
2020International Journal of Radiation Oncology, Biology, Physics5 citations Open access
Semantic Scholar
Postoperative Complications After Distal Pancreatectomy Performed During Cytoreductive Surgery for Gynecologic Malignancies
H. Mahdi, P. Rose, S. Gonzalez, R. Debernardo +3 more
2015International Journal of Gynecologic Cancer5 citations Open access
Semantic Scholar
Efficacy of hyperthermic intraperitoneal chemotherapy and interval debulking surgery in women with advanced uterine serous carcinoma
L. Chambers, D. Chau, M. Yao, A. Costales +4 more
2021Gynecologic Oncology Reports4 citations Open access
Semantic Scholar
Laparoscopic predictability of minimally invasive interval debulking in advanced ovarian cancer: the MIID-SOC trial
A. Costales, E. Crane, L. Chambers, R. Debernardo +4 more
2021Gynecologic Oncology4 citations
Semantic Scholar
Synergistic effect of MDM2 inhibitors and radiotherapy in endometrial cancer
Roberto Vargas, Aaron P. Petty, Daniel J. Lindner, Yvonne Parker +6 more
2025npj Precision Oncology3 citations Open access
Semantic Scholar
Surgical management of spontaneous bowel perforation and fascial dehiscence in a patient on bevacizumab and pembrolizumab in the setting of active Clostridium difficile infection
Mujtaba Mubashir, Brian Tang, R. Debernardo, Xiaoxi Feng
2023BMJ Case Reports3 citations Open access
Semantic Scholar
Development and validation of a comprehensive clinical risk-scoring model for prediction of overall survival in patients with endometrioid endometrial carcinoma.
M. AlHilli, L. Rybicki, C. Carr, M. Yao +5 more
2021Gynecologic Oncology3 citations
Semantic Scholar
Cisplatin and paclitaxel are associated with improved progression-free survival compared to cisplatin alone during interval debulking surgery with hyperthermic intraperitoneal chemotherapy in women with advanced epithelial ovarian cancer
L. Chambers, M. Horowitz, A. Costales, M. Yao +6 more
2021Gynecologic Oncology3 citations
Semantic Scholar
Laparoscopic predictability of minimally invasive interval debulking in advanced ovarian cancer: The MIID-SOC trial.
A. Costales, Erin K Crane, L. Chambers, Meng Yao +6 more
2024Gynecologic Oncology2 citations
Semantic Scholar
Immunogenomic determinants of response to immune checkpoint inhibition in ovarian cancer: Insights from the NRG-GY003 clinical trial
Kelsey R. Monson, Nezar Mehanna, M. Sill, Zhihong Chen +14 more
2026Gynecologic Oncology1 citations
Semantic Scholar
Interval versus primary cytoreductive surgery in BRCA-mutated advanced-stage ovarian/peritoneal/tubal carcinoma.
Peter G. Rose, Sujata Patil, Meng Yao, L. Chambers +4 more
2025International Journal of Gynecological Cancer1 citations
Semantic Scholar
GOG-3068/HOTT: Randomized trial of hyperthermic intraperitoneal chemotherapy with cisplatin at interval cytoreductive surgery followed by niraparib maintenance in patients with newly diagnosed stage III and IV ovarian, primary peritoneal and fallopian tube cancer
Leslie Randall, Austin Miller, David M. O'Malley, Abdulrahman K. Sinno +17 more
2025Gynecologic Oncology1 citations
Semantic Scholar
Extended-duration antibiotics are not associated with a reduction in surgical site infection in patients with ovarian cancer undergoing cytoreductive surgery with large bowel resection.
Julia Chalif, L. Chambers, Meng Yao, M. Kuznicki +4 more
2024Gynecologic Oncology1 citations
Semantic Scholar
Carboplatin, paclitaxel, and pembrolizumab followed by pembrolizumab maintenance for primary treatment of incompletely resected epithelial ovarian cancer
Denise S. Uyar, C. Michener, Erin Bishop, Elizabeth Hopp +8 more
2024Frontiers in Oncology1 citations Open access
Semantic Scholar
Feasibility and safety of hyperthermic intra-peritoneal chemotherapy in patients with ovarian cancer and chronic kidney disease.
C. Mueller, Gabriella Smith, Meng Yao, Johanna Kelley +2 more
2024International Journal of Gynecological Cancer1 citations Open access
Semantic Scholar
Activating the immune system is essential for the efficacy of heated intraperitoneal cisplatin in a murine model of advanced epithelial ovarian cancer (008)
D. Chau, Zahraa Alali, E. Esakov, Olivia G Huffman +4 more
2023Gynecologic Oncology1 citations Open access
Semantic Scholar
The quality and content of hyperthermic intraperitoneal chemotherapy information available to patients: An evaluation of North American hyperthermic intraperitoneal chemotherapy websites.
Sarah L. Remer, T. Connelly, C. Clancy, R. Debernardo +3 more
2023Surgery1 citations
Semantic Scholar
Leveraging the p53 signaling pathway as a radio-sensitization strategy in endometrial cancer
R. Vargas, A. Petty, Brian Yard, Arda Durmaz +4 more
2023bioRxiv1 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Michener×27
Invite
C. Michener — researcher profile on SciRah
P. Rose×26
Invite
P. Rose — researcher profile on SciRah
L. Chambers×26
Invite
L. Chambers — researcher profile on SciRah
M. Yao×19
Invite
M. Yao — researcher profile on SciRah

×13

Invite

A. Costales — researcher profile on SciRah

Invite

R. Vargas — researcher profile on SciRah

Invite

M. Morton — researcher profile on SciRah

A. Chichura×10

Invite

A. Chichura — researcher profile on SciRah

Invite

M. Gruner — researcher profile on SciRah

Invite

M. Horowitz — researcher profile on SciRah

Invite

O. Reizes — researcher profile on SciRah

Invite

H. Mahdi — researcher profile on SciRah